Article info
Neuromuscular
Original research
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
- Correspondence to Dr Valentina Damato, Neuroscience, Catholic University of the Sacred Heart Faculty of Medicine and Surgery, Rome 00168, Italy; valentina.damato{at}unicatt.it
Citation
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
Publication history
- Received March 22, 2022
- Accepted June 28, 2022
- First published July 14, 2022.
Online issue publication
May 17, 2023
Article Versions
- Previous version (15 November 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.